The Advisory Team at Dewpoint Therapeutics provides expert guidance and strategic insights to support the company's mission in applying biomolecular condensates to drug discovery. Comprising seasoned professionals and scientific advisors, the team advises on research direction, potential therapeutic targets, and innovative approaches to address conditions regulated by or arising from condensate dysfunction, including cancer, neurodegeneration, and metabolic diseases.
View all